Satellite Banner
Technology Networks Header
Friday, October 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
BioNitrogen Unveils Revolutionary Technology
Thursday, January 26, 2012
Utilizing proprietary technology the company is able to convert biomass to high-quality, urea fertilizer for the global marketplace.

Simplified and Cost-Effective New Approach to Carbohydrate Determination
Tuesday, January 24, 2012
Thermo Fisher Scientific announces a new study that evaluates disposable gold on polytetrafluoroethylene (Au on PTFE) working electrodes with multiple application conditions.

Simcyp Develops Virtual Laboratory Mouse for Use in Cancer and Toxicology Research
Friday, January 20, 2012
The Simcyp Mouse provides a virtual environment for evaluating drug disposition which will replace the need for some live animal testing in normal as well as transgenic mice, thus reducing and refining preclinical investigation.

Integromics Announces the Release of SeqSolve 2.1
Monday, January 09, 2012
Integromics(R) has announced the release of SeqSolve 2.1(TM), its analytical software package which provides scalable server mode and makes the analysis of Next Generation Sequencing (NGS) data simpler.

Agilent Technologies Names National Center for Genome Resources as a Certified Provider of Target Enrichment Services
Wednesday, January 04, 2012
National Center for Genome Resources (NCGR) has achieved Certified Service Provider status for the Agilent SureSelect Target Enrichment System for next-generation sequencing. NCGR now provides Agilent exome and custom target-enrichment services along with sequencing and analysis for a wide range of genomics studies.

Yissum Introduces a Novel Technology for Manufacturing an Anti-Malaria Drug in Tobacco
Tuesday, December 20, 2011
The work was published in the latest issue of the prestigious Nature Biotechnology journal.

Time-saving DNA and RNA Isolation Kits from Cambio
Thursday, October 20, 2011
Cambio kits for nucleic acid isolation and purification, for use in environmental, clinical, public health and forensic science applications.

Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
Tuesday, October 04, 2011
Optimized content and price to enable wider use of genomic selection.

Agrow Announces Shortlist for 2011 Awards
Saturday, October 01, 2011
The shortlist has been announced for this year’s Agrow Awards, which will honour the best and brightest in the crop protection industry at a gala event in central London.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 99
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv